EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging

William Alvis Faubion,Joel Garland Fletcher,Sharon OByrne,Brian G. Feagan,Willem J. de Villiers,Bruce Salzberg,Scott E. Plevy,Deborah D. Proctor,John F. Valentine,Peter D. Higgins,Jeffrey M. Harris,Lauri Diehl,Lilyan Wright,Gaik Wei Tew,Diana Luca,Karen Basu,Mary E. Keir

EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging

2013

William Alvis Faubion
Joel Garland Fletcher
Sharon OByrne
Brian G. Feagan
Willem J. de Villiers
Bruce Salzberg
Scott E. Plevy
Deborah D. Proctor
John F. Valentine
Peter D. Higgins
Jeffrey M. Harris
Lauri Diehl
Lilyan Wright
Gaik Wei Tew
Diana Luca
Karen Basu
Mary E. Keir

EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging

Keywords:

Interleukin 22
Calprotectin
Biomarker (medicine)
Crohn's disease
Disease
Immunology
Feces
Diabetes mellitus
Medicine
Inflammatory bowel disease
MMP9

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations